I have been focusing on the MC of PYC and trying to get a handle of what the market will value us at when we start to see revenue / profits. I have focused on the ASX listed companies as right now that is where we are. Lets forget for the moment all the pie in the sky theories of us being a CSL . The best example i came up with was TLX because they have revenue and profits. I know from a medical perspective we are not in the same field but regardless they are an ASX listed biotech.
The slide below is an extract from their 22nd August H1 2024 results and the current MC of TLX is 7.3 B which if we were to achieve similar numbers in the reconstructed SP would equate to around $13.5 or $1.35 with the current SOI. Based on what I hope we are able to achieve in the next 24 months these numbers are not unrealistic. Just helps put things in perspective I think
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)